The high rate of side effects from oral immunotherapy in the NIH trial explains the superiority of omalizumab. A clinical ...
We need your help! In the next 24 hours, please ask your House representatives to use the appropriations process to ensure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback